Pepticom utilizes a unique Artificial Intelligence (AI) platform to accelerate and optimize the discovery of novel peptide therapeutics. Their technology, based on research from the Hebrew University, aims to overcome limitations in traditional drug discovery by efficiently identifying and designing peptide candidates.
